Important leprosy drugs after a year’s delay in Nigeria

The World Health Organization has said that people affected by leprosy in Nigeria should be able to treat the disease for the first time in the end of this week.

The country, which reports more than 2,000 new cases in a year, partially gone out of supply as drugs were held after the new rules started.

The WHO said it had asked Nigeria to briefly raise its new test policy and is expecting drugs from India on Sunday.

Leprosy is treated with a combination of various antibiotics, but patients’ health may deteriorate with wounds and nervous damage if left untreated.

Treatment can live between six to 12 months.

But due to lack of drugs in Nigeria, patients have been sent home from hospitals. As drugs suppress the transmission, it increases the risk of spreading the disease.

A public health expert and medical advisor at the Nigerian branch of Leprosy Mission. Samimu Meshelija highlighted the immediate need for the drug.

He told the BBC, “We have thousands of newly diagnosed leprosy patients in various cities, who are waiting for this medicine.”

Dr. Mesheliza said, “We have (drugs), better, because currently these people are suffering, their transmission is going on because they are not being treated.”

The Reuters News Agency spoke to a woman in a hospital in Nasarwa state who said that her condition had deteriorated as she was not able to catch the combination of drugs.

All the fingers of Aval Moses were scattered and their feet discharged the pus. “Before last year, my wounds were healing, but now they are getting worse. The pain is worse,” Ms. Moses has been called.

Nerve damage can be irreversible.

The Drug Authority of Nigeria introduced new rules for drugs aimed at dealing with the import of fake and sub-standard medicines.

In recent years, many drugs have been remembered to fail to meet safety standards.

But new measures have affected the availability of important treatments for leprosy.